Though it is well accepted that the HER-2 gene is not often amplified in primary prostate cancers [62,64-68], our observations together with others have demonstrated that overexpression of HER-2 proteins is associated with CRPC progression [62,69]. This evidence concerns the gene ERBB2 and prostate carcinoma.